These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 27004541)

  • 21. A genetic risk score of 45 coronary artery disease risk variants associates with increased risk of myocardial infarction in 6041 Danish individuals.
    Krarup NT; Borglykke A; Allin KH; Sandholt CH; Justesen JM; Andersson EA; Grarup N; Jørgensen T; Pedersen O; Hansen T
    Atherosclerosis; 2015 Jun; 240(2):305-10. PubMed ID: 25864160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic variation of genes involved in dihydrotestosterone metabolism and the risk of prostate cancer.
    Setlur SR; Chen CX; Hossain RR; Ha JS; Van Doren VE; Stenzel B; Steiner E; Oldridge D; Kitabayashi N; Banerjee S; Chen JY; Schäfer G; Horninger W; Lee C; Rubin MA; Klocker H; Demichelis F
    Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):229-39. PubMed ID: 20056642
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reclassification of prostate cancer risk using sequentially identified SNPs: Results from the REDUCE trial.
    Chen H; Na R; Packiam VT; Conran CA; Jiang D; Tao S; Yu H; Lin X; Meng W; Zheng SL; Brendler CB; Helfand BT; Xu J
    Prostate; 2017 Aug; 77(11):1179-1186. PubMed ID: 28670847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic predisposition to early recurrence in clinically localized prostate cancer.
    Borque Á; del Amo J; Esteban LM; Ars E; Hernández C; Planas J; Arruza A; Llarena R; Palou J; Herranz F; Raventós CX; Tejedor D; Artieda M; Simon L; Martínez A; Carceller E; Suárez M; Allué M; Sanz G; Morote J
    BJU Int; 2013 Apr; 111(4):549-58. PubMed ID: 22759231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic variants in the TEP1 gene are associated with prostate cancer risk and recurrence.
    Gu C; Li Q; Zhu Y; Qu Y; Zhang G; Wang M; Yang Y; Wang J; Jin L; Wei Q; Ye D
    Prostate Cancer Prostatic Dis; 2015 Dec; 18(4):310-6. PubMed ID: 26238235
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A 22-single nucleotide polymorphism Alzheimer's disease risk score correlates with family history, onset age, and cerebrospinal fluid Aβ42.
    Sleegers K; Bettens K; De Roeck A; Van Cauwenberghe C; Cuyvers E; Verheijen J; Struyfs H; Van Dongen J; Vermeulen S; Engelborghs S; Vandenbulcke M; Vandenberghe R; De Deyn PP; Van Broeckhoven C;
    Alzheimers Dement; 2015 Dec; 11(12):1452-1460. PubMed ID: 26086184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DNA repair gene X-ray repair cross-complementing group 1 and xeroderma pigmentosum group D polymorphisms and risk of prostate cancer: a study from North India.
    Mandal RK; Gangwar R; Mandhani A; Mittal RD
    DNA Cell Biol; 2010 Apr; 29(4):183-90. PubMed ID: 20070155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incremental value of a genetic risk score for the prediction of new vascular events in patients with clinically manifest vascular disease.
    Weijmans M; de Bakker PI; van der Graaf Y; Asselbergs FW; Algra A; Jan de Borst G; Spiering W; Visseren FL;
    Atherosclerosis; 2015 Apr; 239(2):451-8. PubMed ID: 25687271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between single-nucleotide polymorphisms in DNA double-strand break repair genes and prostate cancer aggressiveness in the Spanish population.
    Henríquez-Hernández LA; Valenciano A; Foro-Arnalot P; Álvarez-Cubero MJ; Cozar JM; Suárez-Novo JF; Castells-Esteve M; Fernández-Gonzalo P; De-Paula-Carranza B; Ferrer M; Guedea F; Sancho-Pardo G; Craven-Bartle J; Ortiz-Gordillo MJ; Cabrera-Roldán P; Rodríguez-Melcón JI; Herrera-Ramos E; Rodríguez-Gallego C; Lara PC
    Prostate Cancer Prostatic Dis; 2016 Mar; 19(1):28-34. PubMed ID: 26754263
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of prostate-specific antigen on a baseline prostate cancer risk assessment including genetic risk.
    Kader AK; Liss MA; Trottier G; Kim ST; Sun J; Zheng SL; Chadwick K; Lockwood G; Xu J; Fleshner NE
    Urology; 2015 Jan; 85(1):165-70. PubMed ID: 25530379
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Accuracy and completeness in reporting family history of prostate cancer by unaffected men.
    Gaff CL; Aragona C; MacInnis RJ; Cowan R; Payne C; Giles GG; Lindeman GJ
    Urology; 2004 Jun; 63(6):1111-6. PubMed ID: 15183962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Met160Val polymorphism in the TRMPSS2 gene and risk of prostate cancer in a population-based case-control study.
    Lubieniecka JM; Cheteri MK; Stanford JL; Ostrander EA
    Prostate; 2004 Jun; 59(4):357-9. PubMed ID: 15065083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of caspases with an increased prostate cancer risk in north Indian population.
    Mittal RD; Mittal T; Singh AK; Mandal RK
    DNA Cell Biol; 2012 Jan; 31(1):67-73. PubMed ID: 21668377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of prostate cancer association with four single-nucleotide polymorphisms from genome-wide studies and serum phyto-estrogen concentrations.
    Ho CK; Halley L; Wei J; Habib FK
    Prostate Cancer Prostatic Dis; 2012 Dec; 15(4):365-8. PubMed ID: 22733159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of IGFBP3 gene polymorphisms on IGFBP3 serum levels and the risk of prostate cancer in low-risk Korean men.
    Park K; Kim JH; Jeon HG; Byun SS; Lee E
    Urology; 2010 Jun; 75(6):1516.e1-7. PubMed ID: 20350746
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IBD Genetic Risk Profile in Healthy First-Degree Relatives of Crohn's Disease Patients.
    Kevans D; Silverberg MS; Borowski K; Griffiths A; Xu W; Onay V; Paterson AD; Knight J; Croitoru K;
    J Crohns Colitis; 2016 Feb; 10(2):209-15. PubMed ID: 26512135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Calibration of polygenic risk scores is required prior to clinical implementation: results of three common cancers in UKB.
    Wei J; Shi Z; Na R; Resurreccion WK; Wang CH; Duggan D; Zheng SL; Hulick PJ; Helfand BT; Xu J
    J Med Genet; 2022 Mar; 59(3):243-247. PubMed ID: 33443076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reliability of Ancestry-specific Prostate Cancer Genetic Risk Score in Four Racial and Ethnic Populations.
    Shi Z; Zhan J; Wei J; Ladson-Gary S; Wang CH; Hulick PJ; Zheng SL; Cooney KA; Isaacs WB; Helfand BT; ; Koelsch BL; Xu J
    Eur Urol Open Sci; 2022 Nov; 45():23-30. PubMed ID: 36353656
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk Model for Prostate Cancer Using Environmental and Genetic Factors in the Spanish Multi-Case-Control (MCC) Study.
    Gómez-Acebo I; Dierssen-Sotos T; Fernandez-Navarro P; Palazuelos C; Moreno V; Aragonés N; Castaño-Vinyals G; Jiménez-Monleón JJ; Ruiz-Cerdá JL; Pérez-Gómez B; Ruiz-Dominguez JM; Molero JA; Pollán M; Kogevinas M; Llorca J
    Sci Rep; 2017 Aug; 7(1):8994. PubMed ID: 28827750
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Missing single nucleotide polymorphisms in Genetic Risk Scores: A simulation study.
    Chagnon M; O'Loughlin J; Engert JC; Karp I; Sylvestre MP
    PLoS One; 2018; 13(7):e0200630. PubMed ID: 30024900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.